Tag: Enoblituzumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Enoblituzumab

Bokf Has Decreased Regal Entmt Group (RGC) Position; Macrogenics (MGNX) Sentiment Is 1.58

Added to Collection on: 2018-01-03 02:45:00

Tags for this article:

Money
Finance
Short
Price?earnings ratio
Investment
New York Stock Exchange
N share
Wedbush Securities
Regal Entertainment Group
Monoclonal antibodies
Enoblituzumab

Click the tags to see associated articles and topics

View Article Details
EPS for MacroGenics, Inc. (MGNX) Expected At $2.58

Added to Collection on: 2018-02-18 01:26:51

Tags for this article:

Finance
Medicine
Clinical medicine
NASDAQ
Monoclonal antibodies
Immune checkpoint
Enoblituzumab
Margetuximab

Click the tags to see associated articles and topics

View Article Details
Mirae Asset Global Investments Upped Nvidia (NVDA) Position By $74.29 Million; Macrogenics ...

Added to Collection on: 2018-04-28 23:11:15

Tags for this article:

Money
Finance
Nvidia
NASDAQ
Stock
Financial markets
Short
NVDA
Enoblituzumab
Mirae Asset Financial Group
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Discussion stirs around MacroGenics, Inc. (NASDAQ:MGNX) this week; here is what analysts are ...

Added to Collection on: 2018-05-27 23:11:15

Tags for this article:

Money
Finance
Economy
NASDAQ
Short
Monoclonal antibodies
Immune checkpoint
Enoblituzumab
Margetuximab
Flotetuzumab

Click the tags to see associated articles and topics

View Article Details
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule

Added to Collection on: 2020-12-18 16:52:30

Tags for this article:

Life Sciences
Biology
Biotechnology
Johnson & Johnson
Monoclonal antibodies
Janssen Biotech
Janssen Pharmaceutica
Immune system
Biopharmaceutical
Teplizumab
Enoblituzumab
Janssen Biotech Inc.
I MacroGenics Inc.
MacroGenics Inc.

Click the tags to see associated articles and topics

View Article Details
MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results

Added to Collection on: 2021-07-29 19:52:30

Tags for this article:

Monoclonal antibodies
Clinical medicine
Medicine
Life Sciences
Flotetuzumab
Enoblituzumab
Melanoma
Antibody-drug conjugate
MacroGenics Inc.

Click the tags to see associated articles and topics

View Article Details
MacroGenics (NASDAQ:MGNX) Upgraded to Hold at Zacks Investment Research | MarketBeat

Added to Collection on: 2021-08-17 09:11:15

Tags for this article:

Finance
Monoclonal antibodies
Money
Economy
Flotetuzumab
Stock
Enoblituzumab
Securities research
Short
Price?earnings ratio
MacroGenics Inc.

Click the tags to see associated articles and topics

View Article Details
MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus ...

Added to Collection on: 2022-07-09 18:13:56

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immune system
Monoclonal antibodies
Cancer immunotherapy
Enoblituzumab
Immunology
Checkpoint inhibitor
Antibody
Programmed cell death protein 1
PD-1 and PD-L1 inhibitors
MacroGenics Inc.

Click the tags to see associated articles and topics

View Article Details
MacroGenics Announces Closure of CP-MGA271-06 Study - GlobeNewswire

Added to Collection on: 2022-07-09 08:33:04

Tags for this article:

Life Sciences
Medical specialties
Biology
Immunology
Biotechnology
Monoclonal antibodies
Immune system
Enoblituzumab
Antibody
Biopharmaceutical
MacroGenics Inc.

Click the tags to see associated articles and topics

View Article Details
Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal

Added to Collection on: 2022-10-17 20:05:32

Tags for this article:

Medical specialties
Monoclonal antibodies
Immunology
Life Sciences
Immune system
Biotechnology
Enoblituzumab
Gilead Sciences
Bispecific monoclonal antibody
Cancer immunotherapy
MacroGenics

Click the tags to see associated articles and topics

View Article Details